SCHEMBL20973955

SCHEMBL20973955

COc1ccc(C(N)(C(=O)OCC2c3ccccc3-c3ccccc32)c2ccc(C(c3ccccc3)N(C)NC(=O)COc3ccccc3)cc2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KMT2A Q03164 8/20 0.34
▸ MEN1 O00255 6/20 0.34
▸ HPGD P15428 2/20 0.34
▸ TSHR P16473 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ FABP5 Q01469 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ LMNA P02545 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27082137 0.99 NPC1 (0.40) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL29521535 0.86 MEN1 (0.49) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL29385536 0.85 KMT2A (0.43) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL8752790 0.84 NPC1 (0.41) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL28831144 0.83 NPC1 (0.35) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL28191790 0.82 NPC1 (0.39) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL29387123 0.82 MAPT (0.34) NPC1RAB9AKMT2AMEN1GAA
SCHEMBL28069714 0.81 FABP5 (0.45) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL28031978 0.80 NPC1 (0.49) NPC1RAB9AKMT2AMEN1HPGD
SCHEMBL30679137 0.80 NPC1 (0.44) NPC1RAB9AKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161876-B2 Anti-inflammatory nanofibers NORTHWESTERN UNIVERSITY (US) 2021-11-02 — — US disclosed
US-10905750-B2 GRP78 antagonist that block binding of receptor tyrosine kinase orphan receptors as immunotherapy anticancer agents Davidson, Donald J. (US) 2021-02-02 — — US disclosed
US-20190142913-A1 GRP78 ANTAGONIST THAT BLOCK BINDING OF RECEPTOR TYROSINE KINASE ORPHAN RECEPTORS AS IMMUNOTHERAPY ANTICANCER AGENTS CREATIVE BIOTHERAPEUTICS, LLC 2019-05-16 — — US disclosed
Send feedback